Patents

US 12758622 B2: Chitinase administration to the airway to treat inflammation and age-related pulmonary fibrosis

Granted
2026-10-13
Filed
2018-04-11 application 16604979
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Herein is demonstrated that expression of the enzyme chitinase in the lungs of animals is protective against adverse chitin-mediated inflammation and that with impaired chitinase expression, various inflammatory pathways are enhanced, contributing to conditions such as fibrotic lung disease. Further, it is shown that the prevention and treatment of pulmonary fibrosis and other improvements to lung health are achieved by administration of chitinase to the lungs. Additionally, methods of assessing chitinase activity in the lungs provide a novel diagnostic measure of lung health.

Source: PTBLXML, file of 2026-10-13 (ipgb20261013.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 8,781 patentsUS company or organizationOakland, CAREGENTS OF THE UNIVERSITY OF CALIFORNIA State business registration FUZZY medium confidence: same name (legal endings aside) and statePTBLXML, file of 2026-10-13

Inventors

InventorPlacePatentsPerson pageSource
Richard LocksleySan Francisco, CAPTBLXML, file of 2026-10-13
Steven Van DykenSan Francisco, CAPTBLXML, file of 2026-10-13

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/47PTBLXML, file of 2026-10-13
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P11/00PTBLXML, file of 2026-10-13
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/34PTBLXML, file of 2026-10-13
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/6893PTBLXML, file of 2026-10-13
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N9/2442PTBLXML, file of 2026-10-13
C12YEnzymesC12Y302/01014PTBLXML, file of 2026-10-13

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.